Stifel raised the firm’s price target on Oracle (ORCL) to $350 from $250 and keeps a Buy rating on the shares, telling investors that to call last night’s report “a blow-out quarter would be somewhat unfair to Oracle.” In terms of capital expenditures, the company once again raised its FY26 target to about $35B based on the dramatic uptick in RPO, but given the current backlog, and management commentary that RPO is likely to surpass $500B in coming quarters, the firm expects capex spending to “continue to grow at a very healthy clip,” the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
- Oracle upgraded to Buy at BofA after ‘exceptional’ backlog growth
- Oracle’s Promising Growth: Buy Rating Backed by Surging RPO and Strategic AI Investments
- Oracle price target raised to $370 from $270 at Melius Research
- Oracle upgraded to Buy from Neutral at BofA
- Tech companies enabled China’s digital surveillance state, AP reports